欧盟评估扩展使用非转基因解淀粉芽孢杆菌菌株AE-GT生产的谷氨酰胺酶的安全?/h1>
放大字体缩小字体时间?024-07-02 14:50 来源:食品伙伴网 作者: 泽夕
核心提示?024??日,欧盟食品安全局就一种食品酶谷氨酰胺酶(glutaminase)的安全性评价发布意见、/div>
   食品伙伴网讯2024??日, 欧盟食品安全局就一种食品酶 谷氨酰胺酵/a>(glutaminase)的安全性评价发布意见
  据了解,这种食品酶是田a href='//www.sqrdapp.com/news/tag_462.html' class='zdbq' title='非转基因相关食品资讯' target='_blank'>非转基因觢a href='//www.sqrdapp.com/news/tag_338.html' class='zdbq' title='淀粉相关食品资? target='_blank'>淀粈/a> 芽孢杆菌菌株AE-GT生产的,旨在用于18种食品生产过程、/div>
  经过评估,专家小组得出结论,这种食品酶在预期使用条件下不会引起安全问题。部分原文报道如下:
  The food enzyme glutaminase (l-glutamine amidohydrolase; EC 3.5.1.2) is produced with the non-genetically modified Bacillus amyloliquefaciens strain AE-GT by Amano Enzyme Inc. A safety e valuation of this food enzyme was made previously, in which EFSA co ncluded that this food enzyme did not give rise to safety co ncerns when used in five food manufacturing processes. Subsequently, the applicant requested to extend its use to thirteen additio nal processes and to revise the use levels. In this assessment, EFSA updat ed the safety e valuation of this food enzyme when used in a total of eighteen food manufacturing processes. As the food enzymeCtotal organic solids (TOS) are removed from the final foods in two food manufacturing processes, the dietary exposure to the food enzymeCTOS was estimated o nly for the remaining sixteen processes. Dietary exposure was calculated to be up to 0.678 mg TOS/kg body weight per day in European populations. ba sed on the data provided for the previous e valuation and the revised dietary exposure in the present e valuation, the Panel co ncluded that this food enzyme does not give rise to safety co ncerns under the revised intended co nditions of use.
   本文由食品伙伴网食品资讯中心编辑,供网友参考,有任何疑问,请联系news@www.sqrdapp.com、/span>
日期9a href="//www.sqrdapp.com/news/2024-07-02.html">2024-07-02
[ 食品资讯搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]

Baidu
map